Aripiprazole

Imran Qureshi, PharmD, BCPP

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Schizophrenia
  • Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder
  • Adjunctive Treatment of Major Depressive Disorder

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

Maintenance prevention of mood episodes in bipolar disorder I/II

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.